SCHEMBL21722981

SCHEMBL21722981

FC(F)(F)c1ccccc1OCBr

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.49
RXRB P28702 1/20 0.49
RXRG P48443 1/20 0.49
MRGPRX4 Q96LA9 1/20 0.45
PPARG P37231 1/20 0.41
NOTUM Q6P988 1/20 0.41
IDO1 P14902 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LTA4H P09960 1/20 0.41
PTGS2 P35354 1/20 0.41
DRD2 P14416 4/20 0.40
MCL1 Q07820 1/20 0.39
SSTR4 P31391 2/20 0.38
SSTR1 P30872 1/20 0.37
RBP4 P02753 1/20 0.37
MRGPRX1 Q96LB2 1/20 0.37
FAAH O00519 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17842217 0.84 RXRA (0.46) RXRARXRBRXRGMRGPRX4PPARG
SCHEMBL8904282 0.82 RXRA (0.45) RXRARXRBRXRGMRGPRX4NOTUM
SCHEMBL5888832 0.81 MRGPRX4 (0.48) RXRARXRBRXRGMRGPRX4LTA4H
SCHEMBL31706008 0.81 MRGPRX4 (0.48) RXRARXRBRXRGMRGPRX4LTA4H
SCHEMBL5698974 0.81 RXRA (0.50) RXRARXRBRXRGMRGPRX4PPARG
SCHEMBL28060228 0.81 RXRA (0.50) RXRARXRBRXRGMRGPRX4PPARG
SCHEMBL11840784 0.79 RXRA (0.49) RXRARXRBRXRGMRGPRX4PPARG
SCHEMBL6946500 0.79 ALDH1A1 (0.50) RXRARXRBRXRGMRGPRX4L3MBTL1
SCHEMBL535975 0.79 RXRA (0.49) RXRARXRBRXRGMRGPRX4PPARG
SCHEMBL2095584 0.79 RXRA (0.53) RXRARXRBRXRGMRGPRX4PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3837263-A1 NEW HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2021-06-23 EP disclosed
EP-3837264-A1 NEW HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2021-06-23 EP disclosed
WO-2020035425-A1 NEW HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2020-02-20 WO disclosed
WO-2020035424-A1 NEW HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2020-02-20 WO disclosed